作者
Lowell E Schnipper, Nancy E Davidson, Dana S Wollins, Courtney Tyne, Douglas W Blayney, Diane Blum, Adam P Dicker, Patricia A Ganz, J Russell Hoverman, Robert Langdon, Gary H Lyman, Neal J Meropol, Therese Mulvey, Lee Newcomer, Jeffrey Peppercorn, Blase Polite, Derek Raghavan, Gregory Rossi, Leonard Saltz, Deborah Schrag, Thomas J Smith, Peter P Yu, Clifford A Hudis, Richard L Schilsky
发表日期
2015/8/10
期刊
Journal of Clinical Oncology
卷号
33
期号
23
页码范围
2563-2577
出版商
American Society of Clinical Oncology
简介
Health care costs in the United States present a major challenge to the national economic well being. The Centers for Medicare and Medicaid Services (CMS) has projected that US health care spending will reach $4.3 trillion and account for 19.3% of the national gross domestic product by 2019. 1 This growth in spending—both in absolute terms and as a proportion of our gross domestic product—has not been accompanied by commensurate improvements in health outcomes, despite expenditures far exceeding those of other countries. 2-4 One of the fastest growing components of US health care costs is cancer care, the cost of which is now estimated to increase from $125 billion in 2010 to $158 billion in 2020. 1 Although cancer care represents a small fraction of overall health care costs, its contribution to health care cost escalation is increasing faster than those of most other areas because of several factors: the …
引用总数
20152016201720182019202020212022202320243718616010312710690737026